LCM
RDY icon

Logan Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Logan Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,100
Closed -$569K – 645
2026
Q1 		$569K Buy
+41,100
New +$572K 0.02% 238

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Logan Capital Management's RDY Position: Q2 2026 in Review

Logan Capital Management opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 41,306 shares worth $599K. The stake represents 0.02% of the portfolio and ranks #237 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in RDY as recently as Q4 2025.

Logan Capital Management first reported a position in RDY in Q2 2015 and has held it in 43 quarters since. The position peaked at $1.34M in Q3 2021. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Logan Capital Management held 41,306 shares of Dr. Reddy's Laboratories worth $599K as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Logan Capital Management position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.02% of Logan Capital Management's portfolio in Q2 2026, its #237 holding.
  • Logan Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2015 and has held it in 43 quarters since.
  • Logan Capital Management's Dr. Reddy's Laboratories position peaked at $1.34M in Q3 2021.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.